Activation of the Neutrophil NADPH Oxidase Is Inhibited by SB 203580, a Specific Inhibitor of SAPK2/p38
- 7 June 1999
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 259 (2) , 465-470
- https://doi.org/10.1006/bbrc.1999.0759
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin‐1Published by Wiley ,2000
- Differential Effects of a Mitogen-Activated Protein Kinase Kinase Inhibitor on Human Neutrophil Responses to Chemotactic FactorsBiochemical and Biophysical Research Communications, 1997
- A comparison of the substrate specificity of MAPKAP kinase‐2 and MAPKAP kinase‐3 and their activation by cytokines and cellular stressFEBS Letters, 1996
- Phosphorylation of the Respiratory Burst Oxidase Subunit p47 as Determined by Two-dimensional Phosphopeptide MappingJournal of Biological Chemistry, 1996
- PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in VivoJournal of Biological Chemistry, 1995
- Chronic granulomatous diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1994
- Regulation of the human neutrophil NADPH oxidase by the Rac GTP-binding proteinsCurrent Opinion in Cell Biology, 1994
- The requirement of p47 phosphorylation for activation of NADPH oxidase by opsonized zymosan in human neutrophilsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1994
- Absence of cytochrome b reduction in stimulated neutrophils from both female and male patients with chronic granulomatous diseaseFEBS Letters, 1980
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970